Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 4,610 | 4,226 | 6,790 | 4,831 | 3,542 |
| Gross Profit | 4,610 | 4,226 | 6,790 | 4,831 | 3,542 |
| Operating Expenses | 15,356 | 13,810 | 10,667 | 13,598 | 10,293 |
| Operating Income | -10,746 | -9,584 | -3,877 | -8,767 | -6,751 |
| Other Income | 831 | 669 | 762 | 456 | 842 |
| Pre-tax Income | -9,915 | -8,916 | -3,114 | -8,311 | -5,909 |
| Income Tax | -1 | N/A | -215 | 3 | 6 |
| Net Income Continuous | -9,914 | -8,916 | -2,899 | -8,314 | -5,915 |
| Minority Interests | N/A | N/A | N/A | N/A | -1 |
| Net Income | $-9,914 | $-8,916 | $-2,899 | $-8,314 | $-5,922 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.03 | -0.10 | -0.08 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.04 | -0.10 | -0.07 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.03 | -0.10 | -0.08 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.04 | -0.10 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.11 | -0.03 | N/A | N/A |
| EBITDA(a) | $-10,056 | $-8,796 | $-3,117 | $-8,017 | $-5,974 |